| scholarly article | Q13442814 |
| P50 | author | Roongroj Bhidayasiri | Q37836973 |
| P2093 | author name string | Truong DD | |
| P2860 | cites work | Mutations in TITF-1 are associated with benign hereditary chorea | Q24294966 |
| Huntington disease: genetics and epidemiology | Q24675741 | ||
| Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA) | Q28250990 | ||
| Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain | Q29617982 | ||
| Paroxysmal kinesigenic choreoathetosis: a report of 26 patients | Q33589494 | ||
| HIV encephalitis presenting with severe generalized chorea | Q49024362 | ||
| Physical localisation of the chromosomal marker D13S31 places the Wilson disease locus at the junction of bands q14.3 and q21.1 of chromosome 13 | Q57828497 | ||
| Delayed choreoathetosis following acute carbon monoxide poisoning | Q70045990 | ||
| Chorea in systemic lupus erythematosus and "lupus-like" disease: association with antiphospholipid antibodies | Q70346602 | ||
| Abnormalities of the physiology of copper in Wilson's disease. 3. The excretion of copper | Q70668973 | ||
| Chorea in beh�et's syndrome | Q72674184 | ||
| Sydenham Chorea: magnetic resonance imaging reveals permanent basal ganglia injury | Q73089988 | ||
| Hyperkinetic movement disorders during and after acute stroke: the Lausanne Stroke Registry | Q73170752 | ||
| Hyperthyroidism presenting as recurrent short paroxysmal kinesigenic dyskinesia | Q74433576 | ||
| Carbocyanine dyes. Novel markers for labelling neurons | Q95811093 | ||
| Increased rate of suicide among patients with Huntington's disease | Q33620527 | ||
| Benign hereditary chorea--entity or syndrome? | Q33884389 | ||
| Acanthocytosis and neurological disorders. | Q33941160 | ||
| A polymorphic DNA marker genetically linked to Huntington's disease | Q34255139 | ||
| Chorea and its disorders | Q34353562 | ||
| Huntington's disease: a review of the literature on prevalence and treatment of neuropsychiatric phenomena | Q34484850 | ||
| Neurologic outcome of choreoathetoid encephalopathy after cardiac surgery | Q34772427 | ||
| Genetics of movement disorders and ataxia. | Q35048944 | ||
| Chorea disclosing deterioration of polycythaemia vera | Q35509720 | ||
| The epidemiology of Huntington's disease | Q35882166 | ||
| Are cognitive changes the first symptoms of Huntington's disease? A study of gene carriers | Q36317837 | ||
| Chorea in the antiphospholipid syndrome. Clinical, radiologic, and immunologic characteristics of 50 patients from our clinics and the recent literature | Q36866914 | ||
| Differential diagnosis of choreiform tardive dyskinesia | Q37062768 | ||
| Anti-basal ganglia antibodies in acute and persistent Sydenham's chorea | Q40578126 | ||
| Chorea gravidarum | Q40582021 | ||
| Sydenham's chorea. A model for childhood autoimmune neuropsychiatric disorders | Q40692876 | ||
| Psychopharmacologic treatment of pathologic aggression | Q41510588 | ||
| Huntington Disease and the Related Disorder, Dentatorubral-Pallidoluysian Atrophy (DRPLA) | Q41628677 | ||
| Ocular motor abnormalities in Huntington's disease | Q41678637 | ||
| A double-blind trial of tetrabenazine, thiopropazate, and placebo in patients with chorea | Q42230569 | ||
| Hemichorea and hemiballism associated with contralateral hemiparesis and ipsilateral basal ganglia lesions | Q42472743 | ||
| Paraneoplastic chorea associated with CRMP-5 neuronal antibody and lung carcinoma | Q42523560 | ||
| Tetrabenazine treatment for Huntington's disease-associated chorea | Q44240628 | ||
| Tetrabenazine in the treatment of severe pediatric chorea. | Q44464250 | ||
| Cause and course in a series of patients with sporadic chorea | Q45289056 | ||
| Clozapine in Huntington's chorea | Q45290066 | ||
| Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease | Q45290871 | ||
| Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington's disease | Q45291252 | ||
| Psychiatric, genetic, and positron emission tomographic evaluation of persons at risk for Huntington's disease | Q45291899 | ||
| Neuropathological classification of Huntington's disease | Q45297167 | ||
| Riluzole therapy in Huntington's disease (HD). | Q45297539 | ||
| The diagnosis of Huntington's disease | Q45297907 | ||
| Erythrocyte membrane abnormalities in patients with amyotrophic chorea with acanthocytosis. Part 1. Spin labeling studies and lipid analyses | Q45299897 | ||
| Huntington's disease: neurological assessment of potential gene carriers presenting for predictive DNA testing | Q45300569 | ||
| Hereditary nonprogressive chorea of early onset | Q45301157 | ||
| Improvement of Huntington's disease with olanzapine and valproate | Q45301330 | ||
| Motor and cognitive improvements in patients with Huntington's disease after neural transplantation | Q45301920 | ||
| Hereditary benign chorea: clinical and genetic features of a distinct disease | Q45303372 | ||
| A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington's disease | Q45303631 | ||
| Bilateral human fetal striatal transplantation in Huntington's disease. | Q45305502 | ||
| Restricted unilateral Sydenham's chorea: reversible contralateral striatal hypermetabolism demonstrated on single photon emission computed tomographic scanning | Q48130950 | ||
| Dentatorubral-pallidoluysian atrophy or Naito-Oyanagi disease | Q48209189 | ||
| The diversity of neurologic events in systemic lupus erythematosus. Prospective clinical and computed tomographic classification of 82 events in 71 patients | Q48369404 | ||
| Chorea-acanthocytosis: neuropathology of brain and peripheral nerve. | Q48609023 | ||
| P433 | issue | 947 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Huntington's disease | Q190564 |
| P304 | page(s) | 527-534 | |
| P577 | publication date | 2004-09-01 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Postgraduate Medical Journal | Q7234294 |
| P1476 | title | Chorea and related disorders | |
| P478 | volume | 80 |
| Q34560508 | A case of late-onset chorea |
| Q39785257 | A case of vascular hemichorea responding to topiramate |
| Q28504771 | Ablation of D1 dopamine receptor-expressing cells generates mice with seizures, dystonia, hyperactivity, and impaired oral behavior. |
| Q26765818 | Abnormal movements in critical care patients with brain injury: a diagnostic approach |
| Q41841066 | Acute and long‐term response of dopamine nigrostriatal synapses to a single, low‐dose episode of 3‐nitropropionic acid‐mediated chemical hypoxia |
| Q59460890 | Antipsychotikainduzierte tardive Syndrome |
| Q35520657 | Cachexia in malaria and heart failure: therapeutic considerations in clinical practice |
| Q35108608 | Chorea associated with high titers of antiphospholipid antibodies in the absence of antiphospholipid antibody syndrome |
| Q34772888 | Clinical and Neuroimaging Findings of Sydenham's Chorea |
| Q37945484 | Deep brain stimulation in the treatment of chorea |
| Q58597737 | Hemichorea associated with cavernous angioma and a small errhysis: A case report and literature review |
| Q26744786 | Movement Disorders Following Cerebrovascular Lesion in the Basal Ganglia Circuit |
| Q50147063 | Movement disorders in mitochondrial disease |
| Q33636308 | Oromandibular dyskinesia as the initial manifestation of late-onset huntington disease |
| Q53050899 | Phenotypic disruption to orofacial movement topography in conditional mutants with generalized CamKIIa/Cre D1Tox versus striatal-specific DARPP-32/Cre D1Tox ablation of D1 dopamine receptor-expressing cells. |
| Q38085546 | Post-stroke Movement Disorders: Clinical Manifestations and Pharmacological Management |
| Q45288618 | Pregnancy and active Huntington disease: a rare combination. |
| Q42931752 | Reversible Choreoathetosis After the Administration of Ceftriaxone Sodium in Patients With End-Stage Renal Disease |
| Q92671741 | Reversible chorea secondary to uremia in an older adult |
| Q43065095 | Schizophreniform symptoms in Chorea Minor--case report and literature review |
| Q48014197 | Successful Deep Brain Stimulation Surgery With Intraoperative Magnetic Resonance Imaging on a Difficult Neuroacanthocytosis Case |
| Q37777459 | Sydenham's Chorea: A Practical Overview of the Current Literature |
| Q26853651 | Sydenham's chorea in a family with Huntington's disease: case report and review of the literature |
| Q24289511 | Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson’s, Huntington’s, Alzheimer’s, prions, bactericides, chemical toxicology and others as examples |
| Q64289531 | Unilateral Hyperkinetic Choreiform Movements due to Calcification of the Putamen and Caudate from an Underlying Developmental Venous Anomaly |
| Q34829294 | Use of Antiepileptic Drugs for Hyperkinetic Movement Disorders |
| Q38009653 | What’s the role of topiramate in the management of patients with hyperkinetic movement disorders? |
Search more.